HCW Biologics is developing transformative immunotherapies to lengthen healthspan by disrupting inflammaging.
HCW Biologics is an innovative immunotherapy company developing novel therapeutics designed to disrupt the link between chronic, low-grade inflammation and age-related disorders. This field, known as inflammaging, targets the unresolved inflammatory responses and chronic, low-grade inflammation associated with advancing age and believed to be a significant contributing factor to cancer and several chronic conditions, including cardiovascular disease, diabetes, neurodegenerative disease, and autoimmune disease.
Data Provided by Refinitiv. Minimum 15 minutes delayed.